PAR paradigm biopharmaceuticals limited..

Where we at?, page-5

  1. 597 Posts.
    lightbulb Created with Sketch. 150
    Where are we at?

    We are at the hands of the FDA/TGA, now. Thanks Paul. Everyone is frustrated. Balance sheet is shot.

    Paul (and Donna) either has supreme confidence in our data, is acting on the information at non binding agreement stages or is a complete fool. COMPLETE.

    But if the regulators allow us to apply for the programs on offer (BT, AA, Provisional Approval) and our optimal dose is green lighted, we will re-rate if…… our cash position can change.

    Matt and SW will (in my completely nativity) have 1 or 2 shots at obtaining a non dilutive funding and they should be able to achieve this.

    Paul may redeem himself, hard to know

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
46.5¢
Change
0.010(2.20%)
Mkt cap ! $184.8M
Open High Low Value Volume
45.5¢ 48.0¢ 44.0¢ $534.2K 1.168M

Buyers (Bids)

No. Vol. Price($)
1 5245 45.5¢
 

Sellers (Offers)

Price($) Vol. No.
47.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.